Clinical Trial Update: The Effectiveness of Recombinant Coagulation Factor IX With Recombinant Albumin (rIX-FP) in Severe Hemophilia B Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating recombinant coagulation factor IX with recombinant albumin (rIX-FP) in severe Hemophilia B patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• rIX-FP (recombinant coagulation factor IX with recombinant albumin) (recombinant coagulation factor IX with recombinant albumin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hemophilia | Phase 4 | Status: UNKNOWN